Matinas BioPharma Holdings, Inc. (MTNB)
0.79
-0.05
(-6.12%)
USD |
NYAM |
Dec 10, 16:00
0.8075
+0.02
(+2.22%)
After-Hours: 20:00
Matinas BioPharma Holdings EPS Diluted (Quarterly): -0.3955 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.15M |
| Total Expenses (Quarterly) | 2.15M |
| Enterprise Value | 1.910M |
| Earnings Yield | -431.6% |
| Normalized Earnings Yield | -299.38 |